Significance of Choi's and Hans's classification of DLBCL in the clinical prognosis
10.3760/cma.j.issn.1009-9921.2011.05.012
- VernacularTitle:Choi和Hans分型在弥漫大B细胞淋巴瘤预后评价中的意义
- Author:
He LI
;
Jinfen WANG
;
Yanfeng XI
;
Ruifang SUN
;
Wei BAI
;
Jing LI
- Publication Type:Journal Article
- Keywords:
Lymphoma,large-cell,diffuse;
Immunophenotyping;
Prognosis
- From:
Journal of Leukemia & Lymphoma
2011;20(5):292-295,299
- CountryChina
- Language:Chinese
-
Abstract:
Objective To detect the correlation of immunophenotyping of DLBCL with Choi's and Han' s classification to the prognos is. Methods Ninty-nine cases of DLBCL were studied using immunohistochemistry EnVision method for bcl-6, CD10, FOXP1, GCET1, MUM1 in Shanxi cancer hospital. The follow-up was included. All cases they were classified according to Hans' s and Choi' s algorithm. Fluorescence in situ hybridization (FISH) for bcl-6 gene expression (located on chromosome 3q27) was performed on paraffin-embedded tissues of 35 cases. Results In Hans classification, 21 cases were GCB and 78 were nonGCB subtype. In Choi's classification, 23 cases were GCB and 76 cases were nonGCB subtype. According to the both classification, the prognosis in GCB group was much better than that in nonGCB's (P = 0.000). The expression of FOXP1 was inverse proportion to the prognosis (P =0.011), on the contrary GCET1 expression was in proportion to the prognosis (P =0.027). Among all of 35 DLBCL cases, bcl-6 rearrangement was more frequently encountered in the nonGCB type, bcl-6 gene rearrangement was no correlated to bcl-6 protein expression. Conclusion On the basis of classification, GCB group had a better clinical outcome than that of nonGCB group. FOXP1, GCET1, bcl-6 protein expression is associated with different outcome in DLBCL. Both of Choi's and Hans's algorithm play an important role in the immunophenotyping and prognosis.
